Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Betamethasone
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[8] 2, 28, 46, 65, 83, 90, 96, 235 💬
2BETAMETHASONE ACIBUTATE
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
3Betamethasone Oral Solution Period 1 and Period 2
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
4Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
(D00244)		[3] Acetate,
Betamethasone,
Phosphate ion		[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
5Betamethasone solution as intramuscular injection Period 1 and Period 2
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
6Intra-articular Compound Betamethasone
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
7Intraarticular betamethasone
(D00244)		[1] Betamethasone[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
8Phosphate and betamethasone acetate, 2 mL.
(D00244)		[3] Acetate,
Betamethasone,
Phosphate ion		[1] Betamethasone (D00244) 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 235 💬